# Intra-Articular Adelmidrol 2%/Hyaluronic Acid 1% With or Without m/umPEA, in Knee Pain Due to Joint Degeneration.

> **NCT07680101** · NA · NOT_YET_RECRUITING · sponsor: **Universita di Verona** · enrollment: 80 (estimated)

## Conditions studied

- Degenerative Joint Disease of Knee
- Rheumatoid Arthritis

## Interventions

- **DEVICE:** Adelmidrol 2% / Hyaluronic Acid 1%
- **DIETARY_SUPPLEMENT:** micronized Palmitoylethanolamide (mPEA) 300mg + ultramicronized Palmitoylethanolamide (umPEA) 600mg

## Key facts

- **NCT ID:** NCT07680101
- **Lead sponsor:** Universita di Verona
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06
- **Primary completion:** 2027-06
- **Final completion:** 2027-06
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-07-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07680101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07680101, "Intra-Articular Adelmidrol 2%/Hyaluronic Acid 1% With or Without m/umPEA, in Knee Pain Due to Joint Degeneration.". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07680101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*